We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Path Investments Plc | LSE:PATH | London | Ordinary Share | GB00BYQD5059 | ORD GBP0.001 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.27 | - | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
10/9/2020 12:48 | that was some time ago now.. time for an update? | currypasty | |
10/9/2020 12:46 | "As a result, the governing prospectus is nearing completion and filing for FCA approval. We look forward to updating shareholders further as we move towards completion of our acquisition of DTU" | purple11 | |
21/8/2020 07:34 | "matters will be concluded shortly" nearly three weeks later, and nothing yet.. whats the definition of shortly | currypasty | |
03/8/2020 06:21 | Update on Sale of DT Ultravert ("DTU") Interest and Kansas Nitrogen Assets Zoetic International plc (LSE: ZOE), the London-listed vertically integrated CBD and natural resources company, provides a further update on the sale of DTU and its Kansas nitrogen assets to Path Investments plc ("Path"), as previously announced on 27 May 2020 and 8 July 2020 (the "Transaction"). The Transaction has not yet completed due to matters beyond the Company's and Path's control, but the Board remains hopeful that matters will be concluded shortly. The Company and Path have agreed an extension to allow the Transaction to complete. The delay in completion of the Transaction has no material impact on the financial performance of the Company. | currypasty | |
23/7/2020 08:15 | so how long does it take these utter clowns to publish a new prospectus? | purple11 | |
21/7/2020 14:48 | nor can I. | purple11 | |
21/7/2020 05:46 | can't believe this. | fatfish | |
14/7/2020 06:13 | how long has it been now. BORING | fatfish | |
08/7/2020 09:23 | a complete farce from beginning to end. | purple11 | |
07/7/2020 16:13 | "The result of those discussions is that it has been concluded that the Transaction is a reverse takeover under the Listing Rules and the current suspension on the Standard Segment of the Official List and on the Main Market of the London Stock Exchange will continue pending publication of a prospectus. The process of producing the required prospectus is underway and on publication of a prospectus the existing listing will be cancelled and the Ordinary Shares re-admitted to trading ("Readmission"). " wasn't it blindingly obvious it is a reverse takeover??? | currypasty | |
03/7/2020 04:34 | 10th day with no news, just how long does it take. Talk about dragging your feet. | fatfish | |
30/6/2020 10:40 | so how much longer do we have to wait?. these clowns don't know what theyre doing. | purple11 | |
22/6/2020 18:05 | what a suprise | currypasty | |
22/6/2020 16:17 | trading of the Company's ordinary shares on the London Stock Exchange will not now occur on 23 June 2020 as previously anticipated. | fatfish | |
22/6/2020 06:05 | every stock has atleast one good move in it so im holding and seeing how it plays out.gl | purple11 | |
22/6/2020 05:57 | exciting to say PATH should be trading live tomorrow. lets hope DT ULTRAVERT the disruptive technology sets the market alight! | purple11 | |
17/6/2020 06:29 | 17 June 2020 Path Investments plc ("Path" or the "Company") Financial Adviser Appointment Path Investments plc (TIDM: PATH) , the energy and natural resources investment company, is pleased to announce the appointment of Grant Thornton UK LLP as the Company's Financial Adviser with immediate effect. | cwa1 | |
12/6/2020 09:42 | good news.the wait is over | purple11 | |
12/6/2020 06:26 | raised at previous close price raised GBP184,000 by way of an oversubscribed placing of 24,188,760 new ordinary shares of 0.01 pence each ("New Ordinary Shares") at a price of 0.75 pence | currypasty | |
12/6/2020 06:04 | no nasty dilution and we are back trading on the 23rd. lets hope it sets the market alight!gla | purple11 | |
12/6/2020 06:03 | 23 june it is then! Path Investments plc Fundraising & Lifting of Suspension Application 12/06/2020 7:00am UK Regulatory (RNS & others) Path Investments (LSE:PATH) Intraday Stock Chart Friday 12 June 2020 TIDMPATH RNS Number : 7308P Path Investments plc 12 June 2020 This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. Market soundings, as defined in MAR, were taken in respect of the Fundraising with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities. 12 June 2020 Path Investments plc ("Path" or the "Company") Fundraising and Application for Lifting of Suspension Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased to announce that it has raised GBP184,000 by way of an oversubscribed placing of 24,188,760 new ordinary shares of 0.01 pence each ("New Ordinary Shares") at a price of 0.75 pence per New Ordinary Share (the "Placing Price") and the sale of 357,142 ordinary shares of 0.1 pence each held by Path as Treasury Stock at a price of 0.75 pence per share (together the "Fundraising"). Keith, Bayley, Rogers & Co. Limited acted as sole placing agent. It is intended that the proceeds of the Fundraising will be used to fund the exploitation of the commercial benefits of Path's recently announced acquisitions of DT Ultravert and the Kansas Nitrogen Reserves and for general working capital purposes. The Placing Price represents a price equal to the closing mid-market price of 0.75 pence per ordinary share on 15 December 2017, being the last trading date of the Company's ordinary shares on the London Stock Exchange prior to the announcement of the Fundraising. The New Ordinary Shares will represent 10.99 per cent. of the Company's share capital as enlarged by the Fundraising. Christopher Theis, Chief Executive of Path, commented: "The Board is pleased that this oversubscribed Fundraising has been completed successfully. This share issue, together with the proposed 15,000,000 share issue to the vendors at completion of our recently announced acquisition, represents the maximum permissible share issuance during the current 12-month period without the publication of a Prospectus. "We are very excited by the opportunities presented by our acquisition of DT Ultravert and the Kansas Nitrogen Reserves, and in particular the economic and environmental benefits that may be provided from the use of the technology. "This is the first step in the relaunch of Path and I look forward to providing further updates in due course ." Application for Lifting of Suspension and Admission of New Ordinary Shares Completion of the Fundraising is conditional, inter alia, upon admission of the New Ordinary Shares to the standard segment of the Official List of the FCA and to trading on the Main Market of the London Stock Exchange ("Admission"). Application has been made to the London Stock Exchange to lift the current suspension of Path's ordinary shares and for the New Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market; it is expected that Admission of the New Ordinary Shares will take place and that trading will recommence in the Company's ordinary shares at or around 8:00 a.m. on 23 June 2020 | purple11 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions Support: +44 (0) 203 8794 460 | support@advfn.com |
ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil |
ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico |
ADVFN France ADVFN US ADVFN Korea |